Breast cancer risk factors among women (aged years) in Saudi Arabia

Size: px
Start display at page:

Download "Breast cancer risk factors among women (aged years) in Saudi Arabia"

Transcription

1 Breast cancer risk factors among women (aged years) in Saudi Arabia Sulafa T AlQutub, MD, ABCM, MPH In Health policy Public health Department at Jeddah Directorate

2 Introduction Saudi Arabia is considered as High income country and rankedrelatively high- at 34 th_ in Human development index. Between over all Age adjusted incidence rate for BC in KSA= /100,000 respectively, similar incidence was observed in Mecca region which = / The region ranked the second in incidence after the eastern region. Breast cancer ranked the first among Saudi Women aged In 2008 IARC estimated that the age-standardized incidence rate for breast cancer at 22.4 per 100,000 women. Knowledge on risk factors is important for risk assessment, disease cost reduction and for efficient screening and control strategies.

3 Fig. 1 Estimated age-standardised incidence rates of female breast cancer by country, Data taken from GLOBOCAN <ce:cross-ref refid="bib0155"> [31]</ce:cross-ref>. Rates were age-standardised to the WHO World Standard population and expressed per Danny R. Youlden, Susanna M. Cramb, Nathan A.M. Dunn, Jennifer M. Muller, Christopher M. Pyke, Peter D. Baade The descriptive epidemiology of female breast cancer: An international comparison of screening, incidence, survival and mortality Cancer Epidemiology, Volume 36, Issue 3, 2012,

4 Introduction Our case-control study, captured the risk factors among Saudi women at their third decade all the way up to the 5 th decade in Jeddah City. Risk factors assessment were mainly retrieved from Gail model ; the model included age at menarche, age at first live birth (or null parity), family history of breast cancer in first-degree relatives, history of breast biopsy, and history of breast biopsy with a typical hyperplasia. Breast cancer susceptibility genes BRCAI and BRCAII are beyond the scope of this study.

5 Jeddah City within Mecca Region

6 Population and Methods N= cases 134controls 151 cases 166 controls N=315

7 Population and Methods Breast cancer confirmed Cases by histopathology over the last two years were recruited from three different cancer management centers in Jeddah. To minimize the selection bias, we selected both hospital and community controls. Data collection through interview; consisted of an interviewer asking questions to an interviewee.

8 Results Early age at menarche (<12 years), monthly income of at least SR ($ 5333), use of exogenous estrogen and progesterone, and previous breast biopsies or surgeries irrespective of the diagnosis. All were significantly associated with breast cancer. Our study did not conclude any significant relations between body weight and height and premenopausal breast cancer.

9 Disease association to parity, lifetime breastfeeding, and family history Factor Cases Controls OR[95% CI] P-value Total no. of pregnancy < 4 > 4 No response [ ] 0.30 Life time breast feeding Yes No No response [ ] 0.01 Affected family member Yes No [ ] 0.13

10 % Reported regular exercise frequency Reported as yes Reported as yes 0 Cases Controls Reported frequency of exercise (>2 h/week for more than 4 months / year)

11 % Reported regular exercise frequency Odds for exercise frequency among the cases and controls was 1.45 (95% CI ). NS However, the culturally rare exposure to exercise among Saudi women made it difficult to conclude the significantly protective effect of exercise.

12 Frequency of Clinical Breast Examination 70.00% 60.90% 60.00% 50.00% 34.30% 40.00% 30.00% 20.00% 10.00% 0.00% Cases Controls

13 Reported Frequency of screening mammography 65.80% 70.00% 60.00% 50.00% 40.00% 30.00% 22.20% 20.00% 10.00% 0.00% Cases Controls This raise concerns about over diagnosis phenomenon which usually appear more Among women at years.

14 How are we different from Europe and North America regarding the risk factors? Mean Age at the Diagnosis Positive Family History Mean Age at menarche Mean BMI among cases Our study Other s studies ± 40Y 38Y-49Y 4.6% 15-20% 12.4Y 13 and/14y Kg/m 2 <25 kg/m 2 ± Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including women with breast cancer from 117 epidemiological studies, Lancet Oncology, 13 (2012) doi: /s (12)

15 Cost per year of life saved through annual mammography screening Cost/year saved Cost/year saved * cost of $84 for a conventional film-screen mammogram in 1994 US dollars Calculations Based on Rosenquist and Lindfors estimates

16 Recommendation to bridge the gap Epidemiological studies To conduct Survival studies on breast cancer to evaluate the control efforts and to compare them within gulf cities and countries. To Conduct similar studies at different gulf cities and countries! Policy development Implement Regulations on Exogenous estrogen/progesterone prescription and to be prescribed at lowest possible doses and for short periods. Cost and harm assessment for various screening strategies (CBE/screening Mammography) to reduce the burden of the disease. Increase Insurance coverage and access to screening and preventive services.

17 Recommendation to bridge the gap Behavioral interventions Implementing proper breast feeding education programs and programs for healthy life style.

18 Acknowledgment To the chairwoman of Sheikh Mohammed Bin Hussien Al-Amoudi Center of Excellence in Breast Cancer for funding and logistics.

19

JESSE HUANG ( 黄 建 始 ),MD,MHPE,MPH,MBA Professor of Epidemiology Assistant President

JESSE HUANG ( 黄 建 始 ),MD,MHPE,MPH,MBA Professor of Epidemiology Assistant President Breast Cancer Epidemiology i in China JESSE HUANG ( 黄 建 始 ),MD,MHPE,MPH,MBA Professor of Epidemiology Assistant President Chinese Academy of Medical Sciences Peking Union Medical College Medical Center

More information

Breast Imaging Made Brief and Simple. Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA

Breast Imaging Made Brief and Simple. Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA Breast Imaging Made Brief and Simple Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA What women are referred for breast imaging? Two groups of women are referred for

More information

Do Women in Saudi Arabia "Think Pink"?

Do Women in Saudi Arabia Think Pink? Do Women in Saudi Arabia "Think Pink"? Sarah K. Hagi # *, Mawya A. Khafaji # # Assistant Professor, Medical Physics Department of Radiology, Faculty of Medicine King Abdulaziz University, Jeddah, Saudi

More information

How To Decide If You Should Get A Mammogram

How To Decide If You Should Get A Mammogram American Medical Women s Association Position Paper on Principals of Breast Cancer Screening Breast cancer affects one woman in eight in the United States and is the most common cancer diagnosed in women

More information

Cancer Expert Working Group on Cancer Prevention and Screening Prevention and Screening for Breast Cancer

Cancer Expert Working Group on Cancer Prevention and Screening Prevention and Screening for Breast Cancer Cancer Expert Working Group on Cancer Prevention and Screening Prevention and Screening for Breast Cancer Information for women and their families 1 What is breast cancer? The female breast is mainly consisted

More information

Wisconsin Cancer Data Bulletin Wisconsin Department of Health Services Division of Public Health Office of Health Informatics

Wisconsin Cancer Data Bulletin Wisconsin Department of Health Services Division of Public Health Office of Health Informatics Wisconsin Cancer Data Bulletin Wisconsin Department of Health Services Division of Public Health Office of Health Informatics In Situ Breast Cancer in Wisconsin INTRODUCTION This bulletin provides information

More information

Breast Cancer a Health Economic Overview

Breast Cancer a Health Economic Overview Swiss Academy of Multidisciplinary Oncology Breast Cancer a Health Economic Overview Prof. Dr. Thomas D. Szucs Chairman of the Board, Helsana Versicherungen AG Professor of Medicine, Universität Basel

More information

Reduce Your Risk of Breast Cancer

Reduce Your Risk of Breast Cancer Reduce Your Risk of Breast Cancer Reduce Your Risk of Breast Cancer There was no history in my family. But the test was positive and it was breast cancer. I was so shocked, I couldn t believe it. ~ Colette

More information

Office of Population Health Genomics

Office of Population Health Genomics Office of Population Health Genomics Policy: Protocol for the management of female BRCA mutation carriers in Western Australia Purpose: Best Practice guidelines for the management of female BRCA mutation

More information

Case-control studies. Alfredo Morabia

Case-control studies. Alfredo Morabia Case-control studies Alfredo Morabia Division d épidémiologie Clinique, Département de médecine communautaire, HUG Alfredo.Morabia@hcuge.ch www.epidemiologie.ch Outline Case-control study Relation to cohort

More information

No. prev. doc.: 8770/08 SAN 64 Subject: EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS COUNCIL MEETING ON 9 AND 10 JUNE 2008

No. prev. doc.: 8770/08 SAN 64 Subject: EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS COUNCIL MEETING ON 9 AND 10 JUNE 2008 COUNCIL OF THE EUROPEAN UNION Brussels, 22 May 2008 9636/08 SAN 87 NOTE from: Committee of Permanent Representatives (Part 1) to: Council No. prev. doc.: 8770/08 SAN 64 Subject: EMPLOYMENT, SOCIAL POLICY,

More information

Understanding Your Risk of Ovarian Cancer

Understanding Your Risk of Ovarian Cancer Understanding Your Risk of Ovarian Cancer A WOMAN S GUIDE This brochure is made possible through partnership support from Project Hope for Ovarian Cancer Research and Education. Project HOPE FOR OVARIAN

More information

Screening Mammography for Breast Cancer: American College of Preventive Medicine Practice Policy Statement

Screening Mammography for Breast Cancer: American College of Preventive Medicine Practice Policy Statement Screening Mammography for Breast Cancer: American College of Preventive Medicine Practice Policy Statement Rebecca Ferrini, MD, Elizabeth Mannino, MD, Edith Ramsdell, MD and Linda Hill, MD, MPH Burden

More information

19. CANCER OF THE CORPUS UTERI

19. CANCER OF THE CORPUS UTERI 19. CANCER OF THE CORPUS UTERI 19.1. SUMMARY Cancer of the uterus is classified by ICD-10 into three sites cancer of the cervix uteri (cervical cancer; see Chapter 20), cancer of the corpus uteri (uterine

More information

Should I Continue Having Mammograms to Screen for Breast Cancer? A decision aid for women aged 70 and older at their next screening mammogram.

Should I Continue Having Mammograms to Screen for Breast Cancer? A decision aid for women aged 70 and older at their next screening mammogram. Should I Continue Having Mammograms to Screen for Breast Cancer? A decision aid for women aged 70 and older at their next screening mammogram. AUSTRALIAN SCREENING MAMMOGRAPHY DECISION AID TRIAL Why is

More information

Breast Cancer Screening

Breast Cancer Screening Breast Cancer Screening The American Cancer Society and Congregational Health Ministry Team October Module To access this module via the Web, visit www.cancer.org and type in congregational health ministry

More information

Analysing research on cancer prevention and survival. Diet, nutrition, physical activity and breast cancer survivors. In partnership with

Analysing research on cancer prevention and survival. Diet, nutrition, physical activity and breast cancer survivors. In partnership with Analysing research on cancer prevention and survival Diet, nutrition, physical activity and breast cancer survivors 2014 In partnership with Contents About World Cancer Research Fund International 1 Our

More information

BREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader. Two years ago, I was working as a bedside nurse. One of my colleagues felt

BREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader. Two years ago, I was working as a bedside nurse. One of my colleagues felt Ali A. Kader, S. (2010). Breast cancer awareness for women and men. UCQ Nursing Journal of Academic Writing, Winter 2010, 70 76. BREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader Two years

More information

Newborns' Early Medical Screening Coverage Study, 2010

Newborns' Early Medical Screening Coverage Study, 2010 Newborns' Early Medical Screening Coverage Study, 2010 The early tests in all cases is one of the most important elements that help to reduce the rate of diseases among the population, it is also considered

More information

Nicole Kounalakis, MD

Nicole Kounalakis, MD Breast Disease: Diagnosis and Management Nicole Kounalakis, MD Assistant Professor of Surgery Goal of Breast Evaluation The goal of breast evaluation is to classify findings as: normal physiologic variations

More information

Screening for Cancer in Light of New Guidelines and Controversies. Christopher Celio, MD St. Jude Heritage Medical Group

Screening for Cancer in Light of New Guidelines and Controversies. Christopher Celio, MD St. Jude Heritage Medical Group Screening for Cancer in Light of New Guidelines and Controversies Christopher Celio, MD St. Jude Heritage Medical Group Screening Tests The 2 major objectives of a good screening program are: (1) detection

More information

Prostate cancer statistics

Prostate cancer statistics Prostate cancer in Australia The following material has been sourced from the Australian Institute of Health and Welfare Prostate cancer incorporates ICD-10 cancer code C61 (Malignant neoplasm of prostate).

More information

Evaluation and Management of the Breast Mass. Gary Dunnington,, M.D. Department of Surgery Internal Medicine Ambulatory Conference December 4, 2003

Evaluation and Management of the Breast Mass. Gary Dunnington,, M.D. Department of Surgery Internal Medicine Ambulatory Conference December 4, 2003 Evaluation and Management of the Breast Mass Gary Dunnington,, M.D. Department of Surgery Internal Medicine Ambulatory Conference December 4, 2003 Common Presentations of Breast Disease Breast Mass Abnormal

More information

Are You at Risk for Ovarian Cancer?

Are You at Risk for Ovarian Cancer? Are You at Risk for Ovarian Cancer? A Woman s Guide Read this brochure to learn more about ovarian cancer symptoms, risk factors and what you can do to reduce your risk. ALL WOMEN HAVE SOME RISK OF OVARIAN

More information

BREAST CANCER IN THE 21 st CENTURY. The Carolinas Medical Center NorthEast Experience. Garry Schwartz, MD

BREAST CANCER IN THE 21 st CENTURY. The Carolinas Medical Center NorthEast Experience. Garry Schwartz, MD BREAST CANCER IN THE 21 st CENTURY The Carolinas Medical Center NorthEast Experience Garry Schwartz, MD The American Cancer Society's most recent estimates for breast cancer in the United States for 2009

More information

Breast cancer control in Brazil. Gulnar Azevedo e Silva

Breast cancer control in Brazil. Gulnar Azevedo e Silva Breast cancer control in Brazil Gulnar Azevedo e Silva London, May 2014 The burden of breast cancer in Brazil Incidence Age-standardized incidence of breast cancer in Brazil, selected cities Ministério

More information

Skin Cancer: The Facts. Slide content provided by Loraine Marrett, Senior Epidemiologist, Division of Preventive Oncology, Cancer Care Ontario.

Skin Cancer: The Facts. Slide content provided by Loraine Marrett, Senior Epidemiologist, Division of Preventive Oncology, Cancer Care Ontario. Skin Cancer: The Facts Slide content provided by Loraine Marrett, Senior Epidemiologist, Division of Preventive Oncology, Cancer Care Ontario. Types of skin Cancer Basal cell carcinoma (BCC) most common

More information

THINGS TO BE AWARE OF ABOUT PROSTATE AND LUNG CANCER. Lawrence Lackey Jr., M.D. Internal Medicine 6001 W. Outer Dr. Ste 114

THINGS TO BE AWARE OF ABOUT PROSTATE AND LUNG CANCER. Lawrence Lackey Jr., M.D. Internal Medicine 6001 W. Outer Dr. Ste 114 THINGS TO BE AWARE OF ABOUT PROSTATE AND LUNG CANCER Lawrence Lackey Jr., M.D. Internal Medicine 6001 W. Outer Dr. Ste 114 WHAT IS CANCER? The body is made up of hundreds of millions of living cells. Normal

More information

William A. Barber, MD, FACS Amanda. Morehouse, MD, FACS Erin Bowman, MD Anna Deriso, RNC, WHNP, MSN Kristy Donaldson, PA-C

William A. Barber, MD, FACS Amanda. Morehouse, MD, FACS Erin Bowman, MD Anna Deriso, RNC, WHNP, MSN Kristy Donaldson, PA-C 275 Collier Road NW Suite 470 Atlanta, GA 30309 William A. Barber, MD, FACS Amanda. Morehouse, MD, FACS Erin Bowman, MD Anna Deriso, RNC, WHNP, MSN Kristy Donaldson, PA-C www.atlantabreastcare.com Phone:

More information

patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015

patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015 patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015 BRCA1 and BRCA2 Mutations Cancer is a complex disease thought to be caused by several different factors. A few types of cancer

More information

Childhood leukemia and EMF

Childhood leukemia and EMF Workshop on Sensitivity of Children to EMF Istanbul, Turkey June 2004 Childhood leukemia and EMF Leeka Kheifets Professor Incidence rate per 100,000 per year 9 8 7 6 5 4 3 2 1 0 Age-specific childhood

More information

Breast Cancer. CSC Cancer Experience Registry Member, breast cancer

Breast Cancer. CSC Cancer Experience Registry Member, breast cancer ESSENTIALS Breast Cancer Take things one step at a time. Try not to be overwhelmed by the tidal wave of technical information coming your way. Finally you know your body best; you have to be your own advocate.

More information

Breast cancer in the family

Breast cancer in the family Birmingham Women's NHS Foundation Trust Breast cancer in the family Information for women with a slightly increased risk of breast cancer This is a no smoking hospital Breast cancer in the family what

More information

The incidence of leukemia in Saudi Arabia

The incidence of leukemia in Saudi Arabia The incidence of leukemia in Saudi Arabia Descriptive epidemiological analysis of data from the Saudi Cancer Registry (2001-2008) Ibrahim G. Alghamdi, MPhil, PhD, Issam I. Hussain, MPhil, PhD, Mohamed

More information

HEREDITARY BRCA1. Faulty gene INFORMATION LEAFLET. How Do I Reduce My Risk?

HEREDITARY BRCA1. Faulty gene INFORMATION LEAFLET. How Do I Reduce My Risk? HEREDITARY BREAST CANCER BRCA1 Faulty gene INFORMATION LEAFLET How Do I Reduce My Risk? Page 1 CONTENTS Part A 1 What is BRCA1 2 How does BRCA1 affect a person s risk of cancer? 3Testing for BRCA1 4Benefits

More information

A Population Based Risk Algorithm for the Development of Type 2 Diabetes: in the United States

A Population Based Risk Algorithm for the Development of Type 2 Diabetes: in the United States A Population Based Risk Algorithm for the Development of Type 2 Diabetes: Validation of the Diabetes Population Risk Tool (DPoRT) in the United States Christopher Tait PhD Student Canadian Society for

More information

Breast Cancer in the Family

Breast Cancer in the Family Oxford University Hospitals NHS Trust Oxford Regional Genetic Department Breast Cancer in the Family Information for women with a moderately increased risk of breast cancer Breast cancer in the family

More information

Breast Cancer Screening. Dr Jennifer Tan Radiologist Alfred Imaging BreastScreen SLHD, SWSLHD and GWNSW

Breast Cancer Screening. Dr Jennifer Tan Radiologist Alfred Imaging BreastScreen SLHD, SWSLHD and GWNSW Breast Cancer Screening Dr Jennifer Tan Radiologist Alfred Imaging BreastScreen SLHD, SWSLHD and GWNSW Learning Objectives Identify risk factors for breast cancer What to do with this information - GP

More information

Alaska Comprehensive Cancer Control Plan 2011-15

Alaska Comprehensive Cancer Control Plan 2011-15 Alaska Comprehensive Cancer Control Plan 2011-15 Alaska Comprehensive Cancer Plan 2011-2015 STATE of ALASKA Department of Health and Social Services ALASKA Comprehensive Cancer Partnership Prevention Promotion

More information

Cancer Screening. Robert L. Robinson, MD, MS. Ambulatory Conference SIU School of Medicine Department of Internal Medicine.

Cancer Screening. Robert L. Robinson, MD, MS. Ambulatory Conference SIU School of Medicine Department of Internal Medicine. Cancer Screening Robert L. Robinson, MD, MS Ambulatory Conference SIU School of Medicine Department of Internal Medicine March 13, 2003 Why screen for cancer? Early diagnosis often has a favorable prognosis

More information

Referred to Committee on Health and Human Services. SUMMARY Makes various changes concerning the prevention and treatment of obesity.

Referred to Committee on Health and Human Services. SUMMARY Makes various changes concerning the prevention and treatment of obesity. SENATE BILL NO. 0 SENATORS DENIS, SPEARMAN, PARKS, HARDY, KIHUEN; SEGERBLOM AND SMITH MARCH, 0 JOINT SPONSORS: ASSEMBLYMEN DIAZ; BUSTAMANTE ADAMS, CARRILLO, FLORES AND THOMPSON Referred to Committee on

More information

Hormone therapy and breast cancer: conflicting evidence. Cindy Farquhar Cochrane Menstrual Disorders and Subfertility Group

Hormone therapy and breast cancer: conflicting evidence. Cindy Farquhar Cochrane Menstrual Disorders and Subfertility Group Hormone therapy and breast cancer: conflicting evidence Cindy Farquhar Cochrane Menstrual Disorders and Subfertility Group The world of hormone therapy in the 1990 s Throughout the 1970s, 1980s and 1990s

More information

The Burden of Cancer in Asia

The Burden of Cancer in Asia P F I Z E R F A C T S The Burden of Cancer in Asia Medical Division PG283663 2008 Pfizer Inc. All rights reserved. Printed in USA/December 2008 In 2002, 4.2 million new cancer cases 39% of new cases worldwide

More information

Prospective, retrospective, and cross-sectional studies

Prospective, retrospective, and cross-sectional studies Prospective, retrospective, and cross-sectional studies Patrick Breheny April 3 Patrick Breheny Introduction to Biostatistics (171:161) 1/17 Study designs that can be analyzed with χ 2 -tests One reason

More information

The Cross-Sectional Study:

The Cross-Sectional Study: The Cross-Sectional Study: Investigating Prevalence and Association Ronald A. Thisted Departments of Health Studies and Statistics The University of Chicago CRTP Track I Seminar, Autumn, 2006 Lecture Objectives

More information

Ovarian Cancer Genetic Testing: Why, When, How?

Ovarian Cancer Genetic Testing: Why, When, How? Ovarian Cancer Genetic Testing: Why, When, How? Jeffrey Dungan, MD Associate Professor Division of Clinical Genetics Department of Obstetrics & Gynecology Northwestern University Feinberg School of Medicine

More information

DATE NAME: DOB: / / AGE: EMAIL ADDRESS: CELL PHONE NUMBER/BEST CONTACT NUMBER: REFERRING PHYSICIAN: EMERGENCY CONTACT NAME, PHONE NUMBER

DATE NAME: DOB: / / AGE: EMAIL ADDRESS: CELL PHONE NUMBER/BEST CONTACT NUMBER: REFERRING PHYSICIAN: EMERGENCY CONTACT NAME, PHONE NUMBER Mammosafe 5300 North Braeswood Boulevard Suite 4-400 Houston, Texas 77096 832.975.7824 BREAST HISTORY FORM DATE NAME: DOB: / / AGE: EMAIL ADDRESS: CELL PHONE NUMBER/BEST CONTACT NUMBER: REFERRING PHYSICIAN:

More information

Butler Memorial Hospital Community Health Needs Assessment 2013

Butler Memorial Hospital Community Health Needs Assessment 2013 Butler Memorial Hospital Community Health Needs Assessment 2013 Butler County best represents the community that Butler Memorial Hospital serves. Butler Memorial Hospital (BMH) has conducted community

More information

Hormone Replacement Therapy : The New Debate. Susan T. Hingle, M.D.

Hormone Replacement Therapy : The New Debate. Susan T. Hingle, M.D. Hormone Replacement Therapy : The New Debate Susan T. Hingle, M.D. Background Hormone replacement therapy (HRT) is extensively used in the United States, especially for: *treatment of menopausal symptoms

More information

Renal cell carcinoma and body composition:

Renal cell carcinoma and body composition: Renal cell carcinoma and body composition: Results from a case-control control study Ryan P. Theis, MPH Department of Epidemiology and Biostatistics College of Public Health and Health Professions University

More information

Gynecologic Cancer in Women with Lynch Syndrome

Gynecologic Cancer in Women with Lynch Syndrome Gynecologic Cancer in Women with Lynch Syndrome Sarah E. Ferguson, MD FRCSC Division of Gynecologic Oncology, Princess Margaret Hospital, University of Toronto June 11, 2013 Objective 1. To review the

More information

9 Expenditure on breast cancer

9 Expenditure on breast cancer 9 Expenditure on breast cancer Due to the large number of people diagnosed with breast cancer and the high burden of disease related to it, breast cancer is associated with substantial health-care costs.

More information

Predictors of Breast Cancer Treatment Outcomes in Kenyan Women

Predictors of Breast Cancer Treatment Outcomes in Kenyan Women African Journal of Pharmacology and Therapeutics Vol. 2 No. 4 Pages 109-115, 2013 Open Access to full text available at http://journals.uonbi.ac.ke/ajpt Research Article Predictors of Breast Cancer Treatment

More information

Oncology Nursing: A Domain for Nursing Students?

Oncology Nursing: A Domain for Nursing Students? Oncology Nursing: A Domain for Nursing Students? Presented by: Tracy L. Powell BScN, RN, MN Associate Professor School of Nursing and Midwifery- Mount Royal University Calgary, Alberta Outline Impact of

More information

BRCA1 & BRCA2 GeneHealth UK

BRCA1 & BRCA2 GeneHealth UK BRCA1 & BRCA2 GeneHealth UK BRCA1 & BRCA2 What is hereditary breast cancer? Cancer is unfortunately very common, with 1 in 3 people developing cancer at some point in their lifetime. Breast cancer occurs

More information

Strategies for cancer care in Sweden

Strategies for cancer care in Sweden Strategies for cancer care in Sweden Bo Lindblom National Board of Health and Welfare Stockholm, Sweden Commission of inquiry 2007-2009 Principal investigator: DG Kerstin Wigzell Committee members Long

More information

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL) PEER REVIEW HISTORY BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (http://bmjopen.bmj.com/site/about/resources/checklist.pdf)

More information

METHODOLOGICAL ISSUES IN THE MEASURES OF MATERNAL MORBIDITY MORTALITY (MM 1 MM 2 ) Dr. AKO Simon

METHODOLOGICAL ISSUES IN THE MEASURES OF MATERNAL MORBIDITY MORTALITY (MM 1 MM 2 ) Dr. AKO Simon (1) METHODOLOGICAL ISSUES IN THE MEASURES OF MATERNAL MORBIDITY MORTALITY (MM 1 MM 2 ) Dr. AKO Simon Postgraduate Research Training in Reproductive Health 2004 Faculty of Medicine, University of Yaounde

More information

Prevent what is preventable, cure what is curable, provide palliative care for patients in need, and monitor and manage for results.

Prevent what is preventable, cure what is curable, provide palliative care for patients in need, and monitor and manage for results. Proposed PAHO Plan of Action for Cancer Prevention and Control 2008 2015 Prevent what is preventable, cure what is curable, provide palliative care for patients in need, and monitor and manage for results.

More information

Abnormal Uterine Bleeding

Abnormal Uterine Bleeding Abnormal Uterine Bleeding WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 Abnormal uterine bleeding is one of the most common reasons women see their doctors. It can occur at any age and has

More information

NIH Public Access Author Manuscript Genet Med. Author manuscript; available in PMC 2009 August 13.

NIH Public Access Author Manuscript Genet Med. Author manuscript; available in PMC 2009 August 13. NIH Public Access Author Manuscript Published in final edited form as: Genet Med. 2006 September ; 8(9): 571 575. doi:10.1097/01.gim.0000237867.34011.12. Population-based study of the prevalence of family

More information

Breast Cancer Screening in Low- and Middle-Income Countries A Framework To Choose Screening Strategies

Breast Cancer Screening in Low- and Middle-Income Countries A Framework To Choose Screening Strategies Breast Cancer Screening in Low- and Middle-Income Countries A Framework To Choose Screening Strategies Richard Wender, MD Session code: www.worldcancercongress.org A Five Step Framework to Guide Screening

More information

in children less than one year old. It is commonly divided into two categories, neonatal

in children less than one year old. It is commonly divided into two categories, neonatal INTRODUCTION Infant Mortality Rate is one of the most important indicators of the general level of health or well being of a given community. It is a measure of the yearly rate of deaths in children less

More information

Breast Cancer. Presentation by Dr Mafunga

Breast Cancer. Presentation by Dr Mafunga Breast Cancer Presentation by Dr Mafunga Breast cancer in the UK Breast cancer is the second most common cancer in women. Around 1 in 9 women will develop breast cancer It most commonly affects women over

More information

Breast cancer and genetics

Breast cancer and genetics Breast cancer and genetics Cancer and genes Our bodies are made up of millions of cells. Each cell contains a complete set of genes. We have thousands of genes. We each inherit two copies of most genes,

More information

Competency 1 Describe the role of epidemiology in public health

Competency 1 Describe the role of epidemiology in public health The Northwest Center for Public Health Practice (NWCPHP) has developed competency-based epidemiology training materials for public health professionals in practice. Epidemiology is broadly accepted as

More information

Ovarian Cancer. in Georgia, 1999-2003. Georgia Department of Human Resources Division of Public Health

Ovarian Cancer. in Georgia, 1999-2003. Georgia Department of Human Resources Division of Public Health Ovarian Cancer in Georgia, 1999-23 Georgia Department of Human Resources Division of Public Health Acknowledgments Georgia Department of Human Resources......B. J. Walker, Commissioner Division of Public

More information

Basic Study Designs in Analytical Epidemiology For Observational Studies

Basic Study Designs in Analytical Epidemiology For Observational Studies Basic Study Designs in Analytical Epidemiology For Observational Studies Cohort Case Control Hybrid design (case-cohort, nested case control) Cross-Sectional Ecologic OBSERVATIONAL STUDIES (Non-Experimental)

More information

BRCA1 & BRCA2: Genetic testing for hereditary breast and ovarian cancer patient guide

BRCA1 & BRCA2: Genetic testing for hereditary breast and ovarian cancer patient guide BRCA1 & BRCA2: Genetic testing for hereditary breast and ovarian cancer patient guide What is Hereditary? Breast cancer is the most common cancer in women in the U.S. (it affects about 1 in 8 women). Ovarian

More information

The effects of hormone replacement therapy on postmenopausal breast cancer biology and survival

The effects of hormone replacement therapy on postmenopausal breast cancer biology and survival The American Journal of Surgery (2009) 197, 403 407 The Midwest Surgical Association The effects of hormone replacement therapy on postmenopausal breast cancer biology and survival Stephen F. Sener, M.D.*,

More information

Effect of Risk and Prognosis Factors on Breast Cancer Survival: Study of a Large Dataset with a Long Term Follow-up

Effect of Risk and Prognosis Factors on Breast Cancer Survival: Study of a Large Dataset with a Long Term Follow-up Georgia State University ScholarWorks @ Georgia State University Mathematics Theses Department of Mathematics and Statistics 7-28-2012 Effect of Risk and Prognosis Factors on Breast Cancer Survival: Study

More information

Chapter 15 Multiple myeloma

Chapter 15 Multiple myeloma Chapter 15 Multiple myeloma Peter Adamson Summary In the UK and in the 199s, multiple myeloma accounted for around 1 in 8 diagnosed cases of cancer and 1 in 7 deaths from cancer. There was relatively little

More information

Breast Cancer in Young Women: Quality of Life and Survivorship

Breast Cancer in Young Women: Quality of Life and Survivorship Breast Cancer in Young Women: Quality of Life and Survivorship Ann H. Partridge, MD, MPH Dana-Farber Cancer Institute Brigham and Women s Hospital Harvard Medical School Breast Cancer in Young Women is

More information

Vitamin Supplementation amongst Otherwise Healthy Individuals

Vitamin Supplementation amongst Otherwise Healthy Individuals 01.13.14 SOURCE: HTTP://WWW.ONEILLINSTITUTEBLOG.ORG/FOUR-THINGS- PROBABLY-STOP-NAME-PUBLIC-HEALTH-2014/# FOUR THINGS WE SHOULD PROBABLY STOP DOING IN THE NAME OF PUBLIC HEALTH IN 2014 BY BRIAN J. HONERMANN

More information

Protection for you, your finances & your future!

Protection for you, your finances & your future! Group Critical Illness Insurance Protection for you, your finances & your future! AGENDA Who is ACE BCCA s new AD&D The Need for Critical Illness The BCCA CI Program How is the product different Policy

More information

Challenges in assessing disease latency for cancer in environmental epidemiology

Challenges in assessing disease latency for cancer in environmental epidemiology Challenges in assessing disease latency for cancer in environmental epidemiology Peggy Reynolds, Ph.D. Case-only Clustering in Mobile Populations Workshop - November 11-12, 2010 Ann Arbor, Michigan Outline

More information

IMPACT OF TWO INDEPENDENT STRATEGIES TO PROMOTE DOWNSTAGING IN BRAZIL

IMPACT OF TWO INDEPENDENT STRATEGIES TO PROMOTE DOWNSTAGING IN BRAZIL THE ROLE OF EARLY DETECTION IN IMPROVING TREATMENT OUTCOMES FOR BREAST CANCER PATIENTS IN LMICS IMPACT OF TWO INDEPENDENT STRATEGIES TO PROMOTE DOWNSTAGING IN BRAZIL MAIRA CALEFFI, MD, PH.D CHIEF OF BREAST

More information

Official reprint from UpToDate www.uptodate.com 2013 UpToDate

Official reprint from UpToDate www.uptodate.com 2013 UpToDate Official reprint from UpToDate www.uptodate.com 2013 UpToDate Patient information: Breast cancer screening (The Basics) Written by the doctors and editors at UpToDate What is breast cancer screening? Breast

More information

Breast cancer close to the nipple: Does this carry a higher risk ofaxillary node metastasesupon diagnosis?

Breast cancer close to the nipple: Does this carry a higher risk ofaxillary node metastasesupon diagnosis? Breast cancer close to the nipple: Does this carry a higher risk ofaxillary node metastasesupon diagnosis? Erin I. Lewis, BUSM 2010 Cheri Nguyen, BUSM 2008 Priscilla Slanetz, M.D., MPH Al Ozonoff, Ph.d.

More information

Early mortality rate (EMR) in Acute Myeloid Leukemia (AML)

Early mortality rate (EMR) in Acute Myeloid Leukemia (AML) Early mortality rate (EMR) in Acute Myeloid Leukemia (AML) George Yaghmour, MD Hematology Oncology Fellow PGY5 UTHSC/West cancer Center, Memphis, TN May,1st,2015 Off-Label Use Disclosure(s) I do not intend

More information

Measure #112 (NQF 2372): Breast Cancer Screening National Quality Strategy Domain: Effective Clinical Care

Measure #112 (NQF 2372): Breast Cancer Screening National Quality Strategy Domain: Effective Clinical Care Measure #112 (NQF 2372): Breast Cancer Screening National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: Percentage of women 50

More information

VOLLEY FOR THE CURE 15

VOLLEY FOR THE CURE 15 The IHSA would like to acknowledge the Ohio State Activity Association and the Ohio High School Volleyball Coaching Association for information used in this promotional material. Main Objective Educating

More information

PATIENT INFORMATION SHEET PHYSICIAN YOU ARE SEEING TODAY DATE OF OFFICE VISIT REFERRING PHYSICIAN LAST NAME FIRST NAME MI

PATIENT INFORMATION SHEET PHYSICIAN YOU ARE SEEING TODAY DATE OF OFFICE VISIT REFERRING PHYSICIAN LAST NAME FIRST NAME MI 275 Collier Road NW, Suite 470 Atlanta, GA 30309 Tel: 404-351-1002 Fax: 404-350-8290 PATIENT INFORMATION SHEET PHYSICIAN YOU ARE SEEING TODAY DATE OF OFFICE VISIT REFERRING PHYSICIAN LAST NAME FIRST NAME

More information

Efficacy and Tolerability of Antidepressant Duloxetine for Treatment of Hot Flushes in Menopausal Women

Efficacy and Tolerability of Antidepressant Duloxetine for Treatment of Hot Flushes in Menopausal Women Efficacy and Tolerability of Antidepressant Duloxetine for Treatment of Hot Flushes in Menopausal Women Irina Shestakova, MD, PhD Research Center of Obstetrics, Gynecology and Perinatology Department of

More information

CANCER PREVENTION AND CONTROL IN INDIA

CANCER PREVENTION AND CONTROL IN INDIA CANCER PREVENTION AND CONTROL IN INDIA Cherian Varghese Non-communicable diseases including cancer are emerging as major public health problems in India. These diseases are lifestyle related, have a long

More information

Cervical Screening and HPV Vaccine Guidelines In Saudi Arabia. Prof. Mohammed Addar Chairmen Gyneoncology section KKUH, King Saud University

Cervical Screening and HPV Vaccine Guidelines In Saudi Arabia. Prof. Mohammed Addar Chairmen Gyneoncology section KKUH, King Saud University Cervical Screening and HPV Vaccine Guidelines In Saudi Arabia Prof. Mohammed Addar Chairmen Gyneoncology section KKUH, King Saud University Burden of HPV related cancers l l Cervical Cancer of the cervix

More information

WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500. Hormone Therapy

WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500. Hormone Therapy Hormone Therapy WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 At menopause, a woman's body makes less estrogen and she stops having menstrual periods. This is a natural stage in a woman's

More information

Electronic health records to study population health: opportunities and challenges

Electronic health records to study population health: opportunities and challenges Electronic health records to study population health: opportunities and challenges Caroline A. Thompson, PhD, MPH Assistant Professor of Epidemiology San Diego State University Caroline.Thompson@mail.sdsu.edu

More information

Analysis of Population Cancer Risk Factors in National Information System SVOD

Analysis of Population Cancer Risk Factors in National Information System SVOD Analysis of Population Cancer Risk Factors in National Information System SVOD Mužík J. 1, Dušek L. 1,2, Pavliš P. 1, Koptíková J. 1, Žaloudík J. 3, Vyzula R. 3 Abstract Human risk assessment requires

More information

Running head: MALE BREAST CANCER AWARENESS 1

Running head: MALE BREAST CANCER AWARENESS 1 Running head: MALE BREAST CANCER AWARENESS 1 Male Breast Cancer Awareness: Showing an Ounce of Prevention is Worth a Pound of Cure Oakland University Rochester, MI MALE BREAST CANCER AWARENESS 2 Abstract

More information

Summary Measures (Ratio, Proportion, Rate) Marie Diener-West, PhD Johns Hopkins University

Summary Measures (Ratio, Proportion, Rate) Marie Diener-West, PhD Johns Hopkins University This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

Programs. Summary of State Programs and Laws Highlighted in Faces of Maryland s Newly Insured. Medical Assistance for Families (SB 6)

Programs. Summary of State Programs and Laws Highlighted in Faces of Maryland s Newly Insured. Medical Assistance for Families (SB 6) Programs Summary of State Programs and Laws Highlighted in Faces of Maryland s Newly Insured Medical Assistance for Families (SB 6) Medical Assistance for Families provides full health care insurance to

More information

Breast Cancer. Sometimes cells keep dividing and growing without normal controls, causing an abnormal growth called a tumor.

Breast Cancer. Sometimes cells keep dividing and growing without normal controls, causing an abnormal growth called a tumor. Breast Cancer Introduction Cancer of the breast is the most common form of cancer that affects women but is no longer the leading cause of cancer deaths. About 1 out of 8 women are diagnosed with breast

More information

TITLE AUTHOR. ADDRESS FOR CORRESPONDENCE (incl. fax and email) KEYWORDS. LEARNING OBJECTIVES (expected outcomes) SYNOPSIS

TITLE AUTHOR. ADDRESS FOR CORRESPONDENCE (incl. fax and email) KEYWORDS. LEARNING OBJECTIVES (expected outcomes) SYNOPSIS TITLE AUTHOR ADDRESS FOR CORRESPONDENCE (incl. fax and email) KEYWORDS LEARNING OBJECTIVES (expected outcomes) SYNOPSIS Types of Epidemiological Studies: Basic Knowledge Enver Roshi, MD, MPH Genc Burazeri,

More information

Six Degrees of Separation No More: Using Data Linkages to Improve the Quality of Cancer Registry and Study Data

Six Degrees of Separation No More: Using Data Linkages to Improve the Quality of Cancer Registry and Study Data Six Degrees of Separation No More: Using Data Linkages to Improve the Quality of Cancer Registry and Study Data Prepared for the 138th Annual Meeting of the American Public Health Association Denver, CO

More information

Guide to Understanding Breast Cancer

Guide to Understanding Breast Cancer An estimated 220,000 women in the United States are diagnosed with breast cancer each year, and one in eight will be diagnosed during their lifetime. While breast cancer is a serious disease, most patients

More information

Fleet and Marine Corps Health Risk Assessment, 1 January 31 December, 2014

Fleet and Marine Corps Health Risk Assessment, 1 January 31 December, 2014 Fleet and Marine Corps Health Risk Assessment, 1 January 31 December, 2014 Executive Summary The Fleet and Marine Corps Health Risk Appraisal is a 22-question anonymous self-assessment of many of the most

More information

BREAST CANCER RISK ASSESSMENT AND PRIMARY PREVENTION FOR HIGH RISK PATIENTS, RACHEL CATHERINE JANKOWITZ, MD 1

BREAST CANCER RISK ASSESSMENT AND PRIMARY PREVENTION FOR HIGH RISK PATIENTS, RACHEL CATHERINE JANKOWITZ, MD 1 FOR HIGH RISK PATIENTS, RACHEL CATHERINE JANKOWITZ, MD 1 Hello, my name is Rachel Jankowitz, I m an assistant professor of medicine in the Division of Hematology Oncology at the University of Pittsburgh

More information

Cellular/Mobile Phone Use and Intracranial Tumours

Cellular/Mobile Phone Use and Intracranial Tumours Cellular/Mobile Phone Use and Intracranial Tumours September 2008 This document was produced by the National Collaborating Centre for Environmental Health at the BC Centre for Disease Control with funding

More information

Pre test Question 2. Emily D. Babcock, DHSc, PA C, DFAAPA CAPA Annual Conference Palm Springs, California October 4, 2013

Pre test Question 2. Emily D. Babcock, DHSc, PA C, DFAAPA CAPA Annual Conference Palm Springs, California October 4, 2013 Emily D. Babcock, DHSc, PA C, DFAAPA CAPA Annual Conference Palm Springs, California October 4, 2013 Objectives After completion of this presentation, the participant will be able to: Explain the current

More information